TSX-V:NSCI • CA63000Y1034
The current stock price of NSCI.CA is 0.145 CAD. Today NSCI.CA is down by -3.33%. In the past month the price decreased by -6.45%. In the past year, price decreased by -51.67%.
ChartMill assigns a technical rating of 0 / 10 to NSCI.CA. When comparing the yearly performance of all stocks, NSCI.CA is a bad performer in the overall market: 95.44% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to NSCI.CA. NSCI.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
On November 24, 2025 NSCI.CA reported an EPS of -0.01 and a revenue of 9.29M. The company missed EPS expectations and missed revenue expectations (-14.08% surprise).
6 analysts have analysed NSCI.CA and the average price target is 0.64 CAD. This implies a price increase of 339.66% is expected in the next year compared to the current price of 0.145.
For the next year, analysts expect an EPS growth of 18.18% and a revenue growth -7.2% for NSCI.CA
Over the last trailing twelve months NSCI.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -36.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.37% | ||
| ROE | -109.99% | ||
| Debt/Equity | 1 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 362.9M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 69.494M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 68.121M | ||
| MIR | MEDMIRA INC | N/A | 49.29M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 39.3M | ||
| ASG | AURORA SPINE CORP | N/A | 20.849M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 20.501M | ||
| MDX | MEDX HEALTH CORP | N/A | 18.036M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.125M | ||
| VER-H | VERISANTE TECHNOLOGY INC | N/A | 878.8K | ||
| IVC-H | INTERCONNECT VENTURES CORP | N/A | 679.7K | ||
| VVTM | VVT MED INC | N/A |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The firm's devices are used in industries, including chemical, mining, pharma, and others.
NANALYSIS SCIENTIFIC CORP
Unit 105, 90 Freeport Boulevard NE
Calgary ALBERTA T2E 7C3 CA
CEO: Sean Krakiwsky
Employees: 249
Phone: 14037699499
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The firm's devices are used in industries, including chemical, mining, pharma, and others.
The current stock price of NSCI.CA is 0.145 CAD. The price decreased by -3.33% in the last trading session.
NSCI.CA does not pay a dividend.
NSCI.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
NSCI.CA stock is listed on the TSX Venture Exchange exchange.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) currently has 249 employees.